Literature DB >> 3988972

Ketamine: behavioral effects of subanesthetic doses.

M M Ghoneim, J V Hinrichs, S P Mewaldt, R C Petersen.   

Abstract

Effects of subanesthetic doses of ketamine (0.25 and 0.5 mg/kg) on memory, cognition, psychomotor function, subjective moods, and incidence of adverse reactions were investigated in 34 healthy young volunteers. The drug caused impairment of immediate and delayed recall. Most of the impairment was due to interference with retrieval processes. Recovery was virtually complete 60 minutes after administration. The incidence of adverse reactions was high. Benzodiazepines need to be administered even when ketamine is used in subanesthetic doses.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3988972

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  43 in total

1.  Functional impact of allosteric agonist activity of selective positive allosteric modulators of metabotropic glutamate receptor subtype 5 in regulating central nervous system function.

Authors:  Meredith J Noetzel; Jerri M Rook; Paige N Vinson; Hyekyung P Cho; Emily Days; Y Zhou; Alice L Rodriguez; Hilde Lavreysen; Shaun R Stauffer; Colleen M Niswender; Zixiu Xiang; J Scott Daniels; Carrie K Jones; Craig W Lindsley; C David Weaver; P Jeffrey Conn
Journal:  Mol Pharmacol       Date:  2011-10-21       Impact factor: 4.436

Review 2.  Glutamatergic model psychoses: prediction error, learning, and inference.

Authors:  Philip R Corlett; Garry D Honey; John H Krystal; Paul C Fletcher
Journal:  Neuropsychopharmacology       Date:  2010-09-22       Impact factor: 7.853

3.  Nicotine improves working memory span capacity in rats following sub-chronic ketamine exposure.

Authors:  Samantha L Rushforth; Thomas Steckler; Mohammed Shoaib
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

4.  Subtle effects of ketamine on memory when administered following stimulus presentation.

Authors:  David J LaPorte; Teresa A Blaxton; Tamara Michaelidis; Donald U Robertson; Martin A Weiler; Carol A Tamminga; Adrienne C Lahti
Journal:  Psychopharmacology (Berl)       Date:  2005-02-18       Impact factor: 4.530

5.  Phantom limb pain exacerbated by intravenous ketamine.

Authors:  Tetsuya Sakai; Koji Sumikawa
Journal:  J Anesth       Date:  2013-12-01       Impact factor: 2.078

Review 6.  Prefrontal cortex executive processes affected by stress in health and disease.

Authors:  Milena Girotti; Samantha M Adler; Sarah E Bulin; Elizabeth A Fucich; Denisse Paredes; David A Morilak
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-07-06       Impact factor: 5.067

7.  Over-expression of miR-34a induces rapid cognitive impairment and Alzheimer's disease-like pathology.

Authors:  S Sarkar; E B Engler-Chiurazzi; J Z Cavendish; J M Povroznik; A E Russell; D D Quintana; P H Mathers; J W Simpkins
Journal:  Brain Res       Date:  2019-07-08       Impact factor: 3.252

8.  Differential muscarinic and NMDA contributions to visuo-spatial paired-associate learning in rhesus monkeys.

Authors:  Michael A Taffe; Michael R Weed; Tannia Gutierrez; Sophia A Davis; Lisa H Gold
Journal:  Psychopharmacology (Berl)       Date:  2002-01-22       Impact factor: 4.530

9.  Ketamine impairs multiple cognitive domains in rhesus monkeys.

Authors:  Michael A Taffe; Sophia A Davis; Tannia Gutierrez; Lisa H Gold
Journal:  Drug Alcohol Depend       Date:  2002-10-01       Impact factor: 4.492

10.  Acute ketamine administration alters the brain responses to executive demands in a verbal working memory task: an FMRI study.

Authors:  R A E Honey; G D Honey; C O'Loughlin; S R Sharar; D Kumaran; E T Bullmore; D K Menon; T Donovan; V C Lupson; R Bisbrown-Chippendale; P C Fletcher
Journal:  Neuropsychopharmacology       Date:  2004-06       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.